Visualitza per autor "Barkhof, Frederik"
Ara mostrant els elements 1-5 d 5
-
Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis
De Stefano, Nicola; Montalban Gairín, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Barkhof, Frederik (Lippincott Williams & Wilkins, 2022-07) -
Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension
Kappos, Ludwig; Li, David K B; Bar-Or, Amit; Barkhof, Frederik; Traboulsee, Anthony; Montalban, Xavier (Springer, 2024-02) -
Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study
Paul, Friedemann; Calabresi, Peter A.; Green, Ari J.; Kardon, Randy; Sastre Garriga, Jaume; Barkhof, Frederik (Wiley, 2021-12) -
Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis
Granziera, Cristina; Wuerfel, Jens; Calabrese, Massimiliano; De Stefano, Nicola; Enzinger, Christian; Rovira Cañellas, Alex; Barkhof, Frederik (Oxford University Press, 2021-05) -
Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis
Clarke, Margareta Anna; Prados, Ferran; Ciccarelli, Olga; Alberich Jordà, Manel; Pareto Onghena, Deborah; Rodríguez Barranco, Marta; Tur Gomez, Carmen; Rovira Cañellas, Alex; Sastre Garriga, Jaume; Barkhof, Frederik; Chard, Declan; Calvi, Alberto (SAGE Publications, 2023-03)